- Home
- Publications
- Publication Search
- Publication Details
Title
Recent progress and perspectives on prostate cancer biomarkers
Authors
Keywords
Prostate cancer, Biomarker, PSA, PHI, PCA3, S2,3PSA
Journal
International Journal of Clinical Oncology
Volume 22, Issue 2, Pages 214-221
Publisher
Springer Nature
Online
2016-10-11
DOI
10.1007/s10147-016-1049-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness
- (2016) Tendo Sato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
- (2016) Scott A. Tomlins et al. EUROPEAN UROLOGY
- NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
- (2016) Peter R. Carroll et al. Journal of the National Comprehensive Cancer Network
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
- (2015) P. Blume-Jensen et al. CLINICAL CANCER RESEARCH
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer
- (2015) Yuta Kojima et al. PLoS One
- The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis
- (2014) Xin Gou et al. ASIAN JOURNAL OF ANDROLOGY
- Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer
- (2014) Tohru Yoneyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registry
- (2014) E. David Crawford et al. CURRENT MEDICAL RESEARCH AND OPINION
- Biomarkers in prostate cancer
- (2014) David A. Sartori et al. CURRENT OPINION IN ONCOLOGY
- Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy
- (2014) Takuya Koie et al. International Journal of Clinical Oncology
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum tri- and tetra-antennaryN-glycan is a potential predictive biomarker for castration-resistant prostate cancer
- (2014) Yusuke Ishibashi et al. PROSTATE
- A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens
- (2014) Takuya Koie et al. Scandinavian Journal of Urology
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS
- (2013) Massimo Lazzeri et al. BJU INTERNATIONAL
- Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies
- (2013) Dejan Knezevic et al. BMC GENOMICS
- Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam
- (2013) Sigrid Carlsson et al. EUROPEAN UROLOGY
- Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib
- (2013) Koji Miyahara et al. HEPATOLOGY
- Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population
- (2013) R. Jeffrey Karnes et al. JOURNAL OF UROLOGY
- Serum N-Glycan Alteration Associated with Renal Cell Carcinoma Detected by High Throughput Glycan Analysis
- (2013) Shingo Hatakeyama et al. JOURNAL OF UROLOGY
- The Kallikrein Panel for prostate cancer screening: Its economic impact
- (2013) Jeffrey D. Voigt et al. PROSTATE
- Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination
- (2013) Massimo Lazzeri et al. UROLOGY
- The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
- (2012) A. Pettersson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Circulating Tumor Cells: Liquid Biopsy of Cancer
- (2012) C. Alix-Panabieres et al. CLINICAL CHEMISTRY
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis
- (2012) Shigeru Tsuboi INTERNATIONAL JOURNAL OF ONCOLOGY
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases
- (2012) E. David Crawford et al. JOURNAL OF UROLOGY
- Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity
- (2012) TEPPEI OKAMOTO et al. Molecular Medicine Reports
- Two opposing roles of O-glycans in tumor metastasis
- (2012) Shigeru Tsuboi et al. TRENDS IN MOLECULAR MEDICINE
- A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
- (2011) A. J. Vickers et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor
- (2009) Shingo Hatakeyama et al. INTERNATIONAL JOURNAL OF CANCER
- Urinary Prostate Cancer 3 Test: Toward the Age of Reason?
- (2009) Virginie Vlaeminck-Guillem et al. UROLOGY
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started